New Test Helps Catch Whooping Cough
A newly cleared point-of-care test will enable rapid identification of whooping cough, according to a press release from manufacturer Roche.
A newly cleared point-of-care test will enable rapid identification of whooping cough, according to a press release from manufacturer Roche.
An mRNA influenza vaccine was approximately 35% more effective than an inactivated quadrivalent flu vaccine against two different strains, based on new data from a phase 3 randomized trial.
Andrew Wilner is an associate professor of neurology at the University of Tennessee Health Science Center, Memphis, and a seasoned neurologist and epilepsy expert who has mastered the less conventional locum career path.
Infants who demonstrate delays in multiple domains between 9 and 12 months are significantly more likely to still show persistent challenges at follow-up, according to findings from a large population-based study in Israel.
The recombinant herpes zoster vaccine is effective in older adults regardless of a patient’s immunocompromised status, based on data from more than 3 million adults aged 65 years or older.
Today, we are continuing our updates from the recent American Headache Society annual meeting.
Andrew Wilner is an associate professor of neurology at the University of Tennessee Health Science Center, Memphis, and a seasoned neurologist and epilepsy expert who has mastered the less conventional locum career path.
For older adults, the vaccine against respiratory syncytial virus (RSV) appears to be most effective in the first year after administration, according to new research that shows the benefits of the immunization fall roughly 60% within about 1.5 years.